BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferreira DM, Castro RE, Machado MV, Evangelista T, Silvestre A, Costa A, Coutinho J, Carepa F, Cortez-Pinto H, Rodrigues CM. Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease. Diabetologia. 2011;54:1788-1798. [PMID: 21455726 DOI: 10.1007/s00125-011-2130-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Tian Z, Song M, Ma C, Ge Z, Li P. Detecting the Critical States of Type 2 Diabetes Mellitus Based on Degree Matrix Network Entropy by Cross-Tissue Analysis. Entropy 2022;24:1249. [DOI: 10.3390/e24091249] [Reference Citation Analysis]
2 Khanal P, Patil B. Duranta repens Linn reverses hepatic and peripheral insulin resistance in fructose-induced hyperinsulinaemic rats – Experimental and computational findings. South African Journal of Botany 2022;148:469-81. [DOI: 10.1016/j.sajb.2022.05.011] [Reference Citation Analysis]
3 Yamaguchi T, Yoshida K, Murata M, Suwa K, Tsuneyama K, Matsuzaki K, Naganuma M. Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis. Int J Mol Sci 2022;23:6270. [PMID: 35682957 DOI: 10.3390/ijms23116270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yadav AK, Sata TN, Verma D, Mishra AK, Sah AK, Hossain MM, Pant K, Venugopal SK. Free fatty acid-induced miR-181a-5p stimulates apoptosis by targeting XIAP and Bcl2 in hepatic cells. Life Sci 2022;:120625. [PMID: 35551953 DOI: 10.1016/j.lfs.2022.120625] [Reference Citation Analysis]
5 Neri CR, Scapaticci S, Chiarelli F, Giannini C. Liver Steatosis: A Marker of Metabolic Risk in Children. Int J Mol Sci 2022;23:4822. [PMID: 35563210 DOI: 10.3390/ijms23094822] [Reference Citation Analysis]
6 Jiang H, Zhang Z, Yu Y, Chu HY, Yu S, Yao S, Zhang G, Zhang BT. Drug Discovery of DKK1 Inhibitors. Front Pharmacol 2022;13:847387. [PMID: 35355709 DOI: 10.3389/fphar.2022.847387] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Khanal P, Patil BM. Reversal of insulin resistance by Ficus benghalensis bark in fructose-induced insulin-resistant rats. J Ethnopharmacol 2022;284:114761. [PMID: 34678414 DOI: 10.1016/j.jep.2021.114761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kumar S, Duan Q, Wu R, Harris EN, Su Q. Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. Adv Drug Deliv Rev 2021;176:113869. [PMID: 34280515 DOI: 10.1016/j.addr.2021.113869] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
9 Zhao J, Hu Y, Peng J. Targeting programmed cell death in metabolic dysfunction-associated fatty liver disease (MAFLD): a promising new therapy. Cell Mol Biol Lett 2021;26:17. [PMID: 33962586 DOI: 10.1186/s11658-021-00254-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
10 Lin T, Li L, Liang C, Peng L. Network Pharmacology-Based Investigation of the Therapeutic Mechanisms of Action of Danning Tablets in Nonalcoholic Fatty Liver Disease. Evid Based Complement Alternat Med 2021;2021:3495360. [PMID: 33995543 DOI: 10.1155/2021/3495360] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Roszczyc-Owsiejczuk K, Zabielski P. Sphingolipids as a Culprit of Mitochondrial Dysfunction in Insulin Resistance and Type 2 Diabetes. Front Endocrinol (Lausanne) 2021;12:635175. [PMID: 33815291 DOI: 10.3389/fendo.2021.635175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhang R, Song Z, Wang X, Xue J, Xing D. One-step modification to identify dual-inhibitors targeting both pancreatic triglyceride lipase and Niemann-Pick C1-like 1. Eur J Med Chem 2021;216:113358. [PMID: 33725656 DOI: 10.1016/j.ejmech.2021.113358] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Cicuéndez B, Ruiz-Garrido I, Mora A, Sabio G. Stress kinases in the development of liver steatosis and hepatocellular carcinoma. Mol Metab 2021;50:101190. [PMID: 33588102 DOI: 10.1016/j.molmet.2021.101190] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Li Y, Liu Y, Yang M, Wang Q, Zheng Y, Xu J, Zheng P, Song H. A Study on the Therapeutic Efficacy of San Zi Yang Qin Decoction for Non-Alcoholic Fatty Liver Disease and the Underlying Mechanism Based on Network Pharmacology. Evid Based Complement Alternat Med 2021;2021:8819245. [PMID: 33505505 DOI: 10.1155/2021/8819245] [Reference Citation Analysis]
15 Morio B, Panthu B, Bassot A, Rieusset J. Role of mitochondria in liver metabolic health and diseases. Cell Calcium 2021;94:102336. [PMID: 33387847 DOI: 10.1016/j.ceca.2020.102336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
16 Joaquim M, Escobar-Henriques M. Role of Mitofusins and Mitophagy in Life or Death Decisions. Front Cell Dev Biol 2020;8:572182. [PMID: 33072754 DOI: 10.3389/fcell.2020.572182] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
17 Steensels S, Qiao J, Ersoy BA. Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease. Metabolites 2020;10:E283. [PMID: 32660130 DOI: 10.3390/metabo10070283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
18 Tang M, Jiang Y, Jia H, Patpur BK, Yang B, Li J, Yang C. Osteopontin acts as a negative regulator of autophagy accelerating lipid accumulation during the development of nonalcoholic fatty liver disease. Artif Cells Nanomed Biotechnol 2020;48:159-68. [PMID: 31852298 DOI: 10.1080/21691401.2019.1699822] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
19 Liu TT, Liu XT, Chen QX, Shi Y. Lipase Inhibitors for Obesity: A Review. Biomed Pharmacother 2020;128:110314. [PMID: 32485574 DOI: 10.1016/j.biopha.2020.110314] [Cited by in Crossref: 26] [Cited by in F6Publishing: 55] [Article Influence: 13.0] [Reference Citation Analysis]
20 Afonso MB, Castro RE, Rodrigues CMP. Processes exacerbating apoptosis in non-alcoholic steatohepatitis. Clin Sci (Lond) 2019;133:2245-64. [PMID: 31742325 DOI: 10.1042/CS20190068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
21 Kobayashi T, Kanno K, Nguyen PT, Sugiyama A, Kawahara A, Otani Y, Kishikawa N, Ito M, Tazuma S. Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of non-alcoholic steatohepatitis. J Gastroenterol Hepatol 2020;35:2140-50. [PMID: 32365405 DOI: 10.1111/jgh.15088] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Arfianti A, Pok S, Barn V, Haigh WG, Yeh MM, Ioannou GN, Teoh NC, Farrell GC. Exercise retards hepatocarcinogenesis in obese mice independently of weight control. J Hepatol 2020;73:140-8. [PMID: 32302728 DOI: 10.1016/j.jhep.2020.02.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
23 Overi D, Carpino G, Franchitto A, Onori P, Gaudio E. Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis. Cells 2020;9:E590. [PMID: 32131439 DOI: 10.3390/cells9030590] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
24 Hernández-Alvarez MI, Sebastián D, Vives S, Ivanova S, Bartoccioni P, Kakimoto P, Plana N, Veiga SR, Hernández V, Vasconcelos N, Peddinti G, Adrover A, Jové M, Pamplona R, Gordaliza-Alaguero I, Calvo E, Cabré N, Castro R, Kuzmanic A, Boutant M, Sala D, Hyotylainen T, Orešič M, Fort J, Errasti-Murugarren E, Rodrígues CMP, Orozco M, Joven J, Cantó C, Palacin M, Fernández-Veledo S, Vendrell J, Zorzano A. Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease. Cell 2019;177:881-895.e17. [PMID: 31051106 DOI: 10.1016/j.cell.2019.04.010] [Cited by in Crossref: 82] [Cited by in F6Publishing: 107] [Article Influence: 41.0] [Reference Citation Analysis]
25 Donohoe F, Wilkinson M, Baxter E, Brennan DJ. Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer. Int J Mol Sci 2020;21:E1241. [PMID: 32069845 DOI: 10.3390/ijms21041241] [Cited by in Crossref: 10] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
26 Zhang B, Zhang C, Zhang X, Li N, Dong Z, Sun G, Sun X. Atorvastatin promotes AMPK signaling to protect against high fat diet-induced non-alcoholic fatty liver in golden hamsters. Exp Ther Med 2020;19:2133-42. [PMID: 32104276 DOI: 10.3892/etm.2020.8465] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
27 Crombez D, Delcambre S, Nonclercq D, Vander Elst L, Laurent S, Cnop M, Muller RN, Burtea C. Modulation of adiponectin receptors AdipoR1 and AdipoR2 by phage display-derived peptides in in vitro and in vivo models. J Drug Target 2020;28:831-51. [PMID: 31888393 DOI: 10.1080/1061186X.2019.1710840] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Simão AL, Afonso MB, Rodrigues PM, Gama-carvalho M, Machado MV, Cortez-pinto H, Rodrigues CMP, Castro RE. Skeletal muscle miR-34a/SIRT1:AMPK axis is activated in experimental and human non-alcoholic steatohepatitis. J Mol Med 2019;97:1113-26. [DOI: 10.1007/s00109-019-01796-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
29 Boemeke L, Raimundo FV, Bopp M, Leonhardt LR, Fernandes SA, Marroni CA. The correlation of neck circumference and insulin resistance in NAFLD patients. Arq Gastroenterol. 2019;56:28-33. [PMID: 31141077 DOI: 10.1590/s0004-2803.201900000-06] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
30 Mou H, Wu S, Zhao G, Wang J. Changes of Th17/Treg ratio in the transition of chronic hepatitis B to liver cirrhosis and correlations with liver function and inflammation. Exp Ther Med 2019;17:2963-8. [PMID: 30936966 DOI: 10.3892/etm.2019.7299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
31 Pfirrmann D, Huber Y, Schattenberg JM, Simon P. Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study. J Med Internet Res 2019;21:e11250. [PMID: 30602434 DOI: 10.2196/11250] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
32 Bratoeva K, Nikolova S, Merdzhanova A, Stoyanov GS, Dimitrova E, Kashlov J, Conev N, Radanova M. Association Between Serum CK-18 Levels and the Degree of Liver Damage in Fructose-Induced Metabolic Syndrome. Metab Syndr Relat Disord 2018;16:350-7. [PMID: 29989845 DOI: 10.1089/met.2017.0162] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
33 Onyango AN. Cellular Stresses and Stress Responses in the Pathogenesis of Insulin Resistance. Oxid Med Cell Longev 2018;2018:4321714. [PMID: 30116482 DOI: 10.1155/2018/4321714] [Cited by in Crossref: 20] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
34 Kanda T, Matsuoka S, Yamazaki M, Shibata T, Nirei K, Takahashi H, Kaneko T, Fujisawa M, Higuchi T, Nakamura H, Matsumoto N, Yamagami H, Ogawa M, Imazu H, Kuroda K, Moriyama M. Apoptosis and non-alcoholic fatty liver diseases. World J Gastroenterol 2018; 24(25): 2661-2672 [PMID: 29991872 DOI: 10.3748/wjg.v24.i25.2661] [Cited by in CrossRef: 114] [Cited by in F6Publishing: 103] [Article Influence: 28.5] [Reference Citation Analysis]
35 Wilson CH, Kumar S. Caspases in metabolic disease and their therapeutic potential. Cell Death Differ 2018;25:1010-24. [PMID: 29743560 DOI: 10.1038/s41418-018-0111-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
36 Yao H, Tao X, Xu L, Qi Y, Yin L, Han X, Xu Y, Zheng L, Peng J. Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1/AMPK signaling pathway. Pharmacological Research 2018;131:51-60. [DOI: 10.1016/j.phrs.2018.03.017] [Cited by in Crossref: 39] [Cited by in F6Publishing: 51] [Article Influence: 9.8] [Reference Citation Analysis]
37 Lawan A, Bennett AM. Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism. Trends Endocrinol Metab 2017;28:868-78. [PMID: 29128158 DOI: 10.1016/j.tem.2017.10.007] [Cited by in Crossref: 50] [Cited by in F6Publishing: 67] [Article Influence: 10.0] [Reference Citation Analysis]
38 Jung TW, Chung YH, Kim HC, Abd El-Aty AM, Jeong JH. Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle. Mol Cell Endocrinol 2018;470:26-33. [PMID: 29111387 DOI: 10.1016/j.mce.2017.10.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
39 Sakasai-Sakai A, Takata T, Takino JI, Takeuchi M. Impact of intracellular glyceraldehyde-derived advanced glycation end-products on human hepatocyte cell death. Sci Rep. 2017;7:14282. [PMID: 29079763 DOI: 10.1038/s41598-017-14711-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
40 Wilson CH, Nikolic A, Kentish SJ, Keller M, Hatzinikolas G, Dorstyn L, Page AJ, Kumar S. Caspase-2 deficiency enhances whole-body carbohydrate utilisation and prevents high-fat diet-induced obesity. Cell Death Dis 2017;8:e3136. [PMID: 29072701 DOI: 10.1038/cddis.2017.518] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
41 Zhang H, Ta N, Chen P, Wang H. Erchen Decoction and Linguizhugan Decoction Ameliorate Hepatic Insulin Resistance by Inhibiting IRS-1Ser307 Phosphorylation In Vivo and In Vitro. Evid Based Complement Alternat Med 2017;2017:1589871. [PMID: 28630632 DOI: 10.1155/2017/1589871] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
42 Rodrigues PM, Afonso MB, Simão AL, Carvalho CC, Trindade A, Duarte A, Borralho PM, Machado MV, Cortez-Pinto H, Rodrigues CM, Castro RE. miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice. Cell Death Dis 2017;8:e2748. [PMID: 28406477 DOI: 10.1038/cddis.2017.172] [Cited by in Crossref: 39] [Cited by in F6Publishing: 46] [Article Influence: 7.8] [Reference Citation Analysis]
43 Cai CX, Buddha H, Castelino-Prabhu S, Zhang Z, Britton RS, Bacon BR, Neuschwander-Tetri BA. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis. Dig Dis Sci 2017;62:968-78. [PMID: 28194671 DOI: 10.1007/s10620-017-4470-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 8.0] [Reference Citation Analysis]
44 Li C, Li J, Chen Y, Zhong X, Kang M. Effect of curcumin on visfatin and zinc-α2-glycoprotein in a rat model of non-alcoholic fatty liver disease. Acta Cir Bras 2016;31:706-13. [DOI: 10.1590/s0102-865020160110000001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
45 So WY, Leung PS. Irisin ameliorates hepatic glucose/lipid metabolism and enhances cell survival in insulin-resistant human HepG2 cells through adenosine monophosphate-activated protein kinase signaling. Int J Biochem Cell Biol 2016;78:237-47. [PMID: 27452313 DOI: 10.1016/j.biocel.2016.07.022] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 5.8] [Reference Citation Analysis]
46 Afonso MB, Rodrigues PM, Simão AL, Castro RE. Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma. J Clin Med 2016;5:E30. [PMID: 26950158 DOI: 10.3390/jcm5030030] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 9.7] [Reference Citation Analysis]
47 Rodrigues PM, Afonso MB, Simão AL, Borralho PM, Rodrigues CMP, Castro RE. Inhibition of NF-κB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocellular apoptosis. Sci Rep 2015;5:17528. [PMID: 26621219 DOI: 10.1038/srep17528] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
48 . What it means to receive the UEG Rising Star Award. United European Gastroenterol J 2015;3:400-2. [PMID: 26425345 DOI: 10.1177/2050640615596322] [Reference Citation Analysis]
49 Afonso MB, Rodrigues PM, Carvalho T, Caridade M, Borralho P, Cortez-Pinto H, Castro RE, Rodrigues CM. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis. Clin Sci (Lond). 2015;129:721-739. [PMID: 26201023 DOI: 10.1042/cs20140732] [Cited by in Crossref: 98] [Cited by in F6Publishing: 104] [Article Influence: 14.0] [Reference Citation Analysis]
50 Mach J, Huizer-Pajkos A, Kane A, Jones B, McKenzie C, Mitchell SJ, de Cabo R, Cogger VC, Le Couteur DG, Hilmer SN. The effect of aging on mitochondrial and cytosolic hepatic intrinsic death pathway and apoptosis associated proteins in Fischer 344 rats. Exp Gerontol. 2015;67:54-61. [PMID: 25910621 DOI: 10.1016/j.exger.2015.04.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
51 Natarajan SK, Ingham SA, Mohr AM, Wehrkamp CJ, Ray A, Roy S, Cazanave SC, Phillippi MA, Mott JL. Saturated free fatty acids induce cholangiocyte lipoapoptosis. Hepatology 2014;60:1942-56. [PMID: 24753158 DOI: 10.1002/hep.27175] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
52 Ivey R, Desai M, Green K, Sinha-Hikim I, Friedman TC, Sinha-Hikim AP. Additive effects of nicotine and high-fat diet on hepatocellular apoptosis in mice: involvement of caspase 2 and inducible nitric oxide synthase-mediated intrinsic pathway signaling. Horm Metab Res 2014;46:568-73. [PMID: 24830635 DOI: 10.1055/s-0034-1375610] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
53 Ferreira DM, Simão AL, Rodrigues CM, Castro RE. Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease. FEBS J 2014;281:2503-24. [PMID: 24702768 DOI: 10.1111/febs.12806] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
54 Tiao MM, Huang LT, Chen CJ, Sheen JM, Tain YL, Chen CC, Kuo HC, Huang YH, Tang KS, Chu EW, Yu HR. Melatonin in the regulation of liver steatosis following prenatal glucocorticoid exposure. Biomed Res Int 2014;2014:942172. [PMID: 24822223 DOI: 10.1155/2014/942172] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
55 Dorn C, Engelmann JC, Saugspier M, Koch A, Hartmann A, Müller M, Spang R, Bosserhoff A, Hellerbrand C. Increased expression of c-Jun in nonalcoholic fatty liver disease. Lab Invest 2014;94:394-408. [PMID: 24492282 DOI: 10.1038/labinvest.2014.3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 54] [Article Influence: 5.3] [Reference Citation Analysis]
56 Ferreira DM, Afonso MB, Rodrigues PM, Simão AL, Pereira DM, Borralho PM, Rodrigues CM, Castro RE. c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver. Mol Cell Biol 2014;34:1100-20. [PMID: 24421392 DOI: 10.1128/MCB.00420-13] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 6.1] [Reference Citation Analysis]
57 Jylhävä J, Lehtimäki T, Jula A, Moilanen L, Kesäniemi YA, Nieminen MS, Kähönen M, Hurme M. Circulating cell-free DNA is associated with cardiometabolic risk factors: the Health 2000 Survey. Atherosclerosis. 2014;233:268-271. [PMID: 24529155 DOI: 10.1016/j.atherosclerosis.2013.12.022] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
58 Li M, Zeng T, Liu R, Chen L. Detecting tissue-specific early warning signals for complex diseases based on dynamical network biomarkers: study of type 2 diabetes by cross-tissue analysis. Briefings in Bioinformatics 2014;15:229-43. [DOI: 10.1093/bib/bbt027] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 8.2] [Reference Citation Analysis]
59 Herold C, Rennekampff HO, Engeli S. Apoptotic pathways in adipose tissue. Apoptosis 2013;18:911-6. [DOI: 10.1007/s10495-013-0848-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
60 Amir M, Liu K, Zhao E, Czaja MJ. Distinct functions of JNK and c-Jun in oxidant-induced hepatocyte death. J Cell Biochem 2012;113:3254-65. [PMID: 22644775 DOI: 10.1002/jcb.24203] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
61 Basseri S, Lhoták S, Fullerton MD, Palanivel R, Jiang H, Lynn EG, Ford RJ, Maclean KN, Steinberg GR, Austin RC. Loss of TDAG51 results in mature-onset obesity, hepatic steatosis, and insulin resistance by regulating lipogenesis. Diabetes 2013;62:158-69. [PMID: 22961087 DOI: 10.2337/db12-0256] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
62 Castro RE, Ferreira DM, Afonso MB, Borralho PM, Machado MV, Cortez-Pinto H, Rodrigues CM. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. J Hepatol. 2013;58:119-125. [PMID: 22902550 DOI: 10.1016/j.jhep.2012.08.008] [Cited by in Crossref: 203] [Cited by in F6Publishing: 225] [Article Influence: 20.3] [Reference Citation Analysis]
63 Sabapathy K. Role of the JNK pathway in human diseases. Prog Mol Biol Transl Sci. 2012;106:145-169. [PMID: 22340717 DOI: 10.1016/B978-0-12-396456-4.00013-4] [Cited by in Crossref: 86] [Cited by in F6Publishing: 91] [Article Influence: 8.6] [Reference Citation Analysis]
64 Rasul S, Wagner L, Kautzky-Willer A. Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus. Endocrine 2012;42:496-505. [PMID: 22820893 DOI: 10.1007/s12020-012-9754-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
65 Farrell GC, van Rooyen D, Gan L, Chitturi S. NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. Gut Liver. 2012;6:149-171. [PMID: 22570745 DOI: 10.5009/gnl.2012.6.2.149] [Cited by in Crossref: 265] [Cited by in F6Publishing: 249] [Article Influence: 26.5] [Reference Citation Analysis]
66 Magkos F, Su X, Bradley D, Fabbrini E, Conte C, Eagon JC, Varela JE, Brunt EM, Patterson BW, Klein S. Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. Gastroenterology. 2012;142:1444-1446.e2. [PMID: 22425588 DOI: 10.1053/j.gastro.2012.03.003] [Cited by in Crossref: 122] [Cited by in F6Publishing: 121] [Article Influence: 12.2] [Reference Citation Analysis]
67 Machado MV, Ferreira DM, Castro RE, Silvestre AR, Evangelista T, Coutinho J, Carepa F, Costa A, Rodrigues CM, Cortez-Pinto H. Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance. PLoS One. 2012;7:e31738. [PMID: 22359625 DOI: 10.1371/journal.pone.0031738] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]